Effects of chronic treatment with haloperidol on [3H]PK 11195 binding in the rat brain and peripheral tissues

Neuropharmacology

Volumn 35, Issue 8, 1996, Pages 1075-1079

  Kurumaji, A ^a   Kaneko, K ^a   Toru, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Chronic treatment; Haloperidol; Olfactory bulb; Peripheral type benzodiazepine receptors; PK 11195; Rat

Indexed keywords

BENZODIAZEPINE RECEPTOR; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; ISOQUINOLINES; MALE; MEMBRANES; NERVE TISSUE PROTEINS; OLFACTORY BULB; RATS; RATS, WISTAR; RECEPTORS, GABA-A;

EID: 0030458526     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(96)00040-8     Document Type: Article

References (27)

1. Antkiewicz-Michaluk L., Guidotti A. and Krueger K. E. (1988) Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. Molec. Pharmacol. 34: 272-278.
2. 3H]PK 11195 to cerebral cortex and peripheral tissues of various species: species difference and heterogenity in peripheral benzodiazepine binding sites. J. Neurochem. 49: 1407-1414.
3. Basil A. S. and Skolnick P. (1986) Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain. J. Neurochem. 46: 305-308.
4. 3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. J. Neurochem. 41: 1774.
5. 3 ligand: a critical analysis of animal models of cerebral ischemia and neurodegeneration. Brain Res. 522: 275-289.
6. De Souza E. B., Anholt R. R. H., Murphy K. M. M., Snyder S. H. and Kuhar M. J. (1985) Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adreal, and testeis. Endocrinology 116: 567-573.
7. Farges R., Joseph-Liauzun E., Shire D., Caput D., Le Fur G., Loison G. and Ferrara P. (1993) Molecular basis for the different binding properties of benzodiazepines to human and bovine peripheral-type benzodiazepine receptors. FEBS 335: 305-308.
8. Gavish M., Weizman A., Karp L., Tyano S. and Tanne Z. (1986) Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenics. Eur. J. Pharmacol. 121: 275-279.
9. Gavish M., Weizman R., Becker D. and Tanne Z. (1988) Effects of chronic haloperidol treatment on peripheral benzodiazepine binding sites in cerebral cortex of rats. J. neural Transm. 74: 109-116.
10. Gavish M. and Weizman R. (1989) Effects of chronic chlorpromazine treatment on peripheral benzodiazepine binding sites in heart, kidney, and cerebral cortex of rats. J. Neurochem. 52: 1553-1558.
11. Itzhak Y., Baker L. and Norenberg M. (1993) Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 9: 211-218.
12. Krueger K. E. and Papadopoulous V. (1993) The role of Mitochondrial benzodiazepine receptors in steroidgenesis. In Perpheral Benzodiazepine Receptors (Giesen-Crouse E, Ed.), pp. 89-109. Academic Press, London.
13. 2 dopamine receptors in brain with subtype-specific antibody. Proc. natn. Acad. Sci. U.S.A. 90: 8861-8864.
14. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. biol. Chem. 193: 265-275.
15. Macrides F. and Davis B. J. (1983) The olfactory bulb. In: Chemical Neuroanatomy (Emson P.C., Ed.), pp. 391-426. Raven Press, New York. .
16. McLean S. and Weber R. (1988) Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain. Neuroscience 25: 259-269.
17. 3H]-Spiperone binding sites in brain: autoradiographic localization of receptors. Brain Res. 213: 277-289.
18. Parola A. L., Stump D. G., Pepperl D. J., Krueger K. E., Regan J. W. and Laird II H. E. (1991) Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquiniline binding protein. J. biol. Chem. 266: 14082-14087.
19. Parola A. L., Yamamura H. I. and Laird II H. E. (1993) Minireview: peripheral-type benzodiazepine receptors. Life Sci. 52: 1329-1342.
20. Rind J., Mattei M. G., Dumont X., Guillemot J. C., Le Fur G., Caput D. and Ferrara P. (1991) Molecular cloning and chromosomal localization of a human peripheral-type benzodiazepine receptor. Eur. J. Biochem. 195: 305-311.
21. 3H] Ro5-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur. J. Pharmacol. 71: 173-175.
22. 3HRo-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res. 248: 396-401.
23. Seeman P. (1995) Dopamine receptors: clinical correlates. In: Psychopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., Eds), pp. 295-302. Raven Press, New York.
24. Sprengel R., Werner P., Seeburg P. H., Mukhin A. G., Santi M. R., Grayson D. R., Guidotti A. and Krueger K. E. (1989) Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. J. biol. Chem. 264: 20415-20421.
25. Stephenson D. T., Schober D. A., Smalstig E. B., Mincy R. E., Gehlert D. R. and Clemens J. A. (1995) Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 15: 5263-5274.
26. Syapin P. J. and Skolnick P. (1979) Characterization of benzodiazepine binding sites in cultured cells of neural origin. J. Neurochem. 32: 1047-1051.
27. Tanne Z., Weizman R., Karp L., Katz Y., Tyano S. and Gavish M. (1987) Lack of effects of 28 days of neuroleptic treatment on platelet benzodiazepine binding sites in schizophrenics. Neuropsychobiology 17: 121-123.